Meropenem

This classification denotes a beta-lactam antibiotic with the molecular formula C17H25N3O5S.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FV9J3JU8B1, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, trihydrate, (4r-(3(3s*,5s*),4alpha,5beta,6beta(r*)))- but generally known as meropenem, which bears US NIH Compound Identifier 60706. European Medicines Agency schedules Meropenem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08778MIG. World Health Organization schedules meropenem in its Anatomical Therapeutic Chemical (ATC) Classification. MEROPENEM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule meropenem under HS 29419000 and SITC 54139. As of Q4 2014, MEROPENEM remains the US FDA Preferred Term for this commodity. Meropenem bears US NLM identifiers UMLS ID C0066005 and NCI Concept Code C1160. SMILES: S(C1=C(N2C(C(C2=O)C(O)C)C1C)C(=O)O)C1CC(NC1)C(=O)N(C)C.O.O.O.